^™middle.

Gathering signals...

The Hydration Pharmaceuticals Company (ASX:HPC) — Material Events

ASX:HPC · 8 articles in the last 12 months · 100% assessed

Click a band to jump to that tier

Major ≥90 Significant 75–89 Notable 50–74 Routine <50 Not assessed

Significant Score 75–89

4

Hydralyte USA Raises A$392k, Revamps Board and Cuts Costs to Boost US GrowthMedium

Hydralyte USA raises A$392k, appoints new board members, and plans cost cuts

15 June 2026 ·Capital Raising and Board Changes ·85

Hydralyte USA Cuts Cash Burn 42% While Launching New Brain and Gut Health ProductsMedium

Hydralyte USA Q3 FY25 sales rise 6%, operating cash burn down 42%, new product launches and US retail expansion underway

31 Oct 2025 ·Quarterly Report and Appendix 4C ·75

Hydralyte USA Boosts Sales 11% with New Brain Support LaunchMedium

Hydralyte USA Q3 Sales Up 11%, Launches New Brain Support Product

3 Oct 2025 ·Company Announcement ·75

Hydralyte USA Boosts Sales 8.5% Ahead of New Brain and Gut Health LaunchesMedium

Hydralyte USA Q2 FY25 sales up 8.5%, new brain and gut health products launching soon, EBITDA loss narrows

31 July 2025 ·Quarterly Report and Appendix 4C ·75

Notable Score 50–74

4

Hydration Pharmaceuticals Reports $2.86M Loss, Eyes Strategic Moves Amid Trading HaltMedium

Hydration Pharmaceuticals relodges FY25 Annual Report amid trading halt; reports $2.86M loss and ongoing cost-cutting

1 May 2026 ·Annual Report Relodgement ·70

Hydralyte USA Cuts Costs by US$25K Monthly, Resolves Supply ConstraintsMedium

Hydralyte USA cuts costs by US$25K/month, resolves supply issues, replenishes inventory

17 Feb 2026 ·Company Announcement ·70

Hydration Pharmaceuticals Cuts Losses by 55% Amid US Market Focus and Cost CutsMedium

Hydration Pharmaceuticals halves loss, cuts costs, and raises capital amid US market focus

29 Aug 2025 ·Half Year Report and Appendix 4D ·60

HPC Returns to ASX Trading After Reporting $2.86M LossMedium

HPC Reinstated to ASX Quotation from 4 May 2026

4 May 2026 ·Reinstatement to Quotation ·50

Not Assessed Low Score, or missing data

0

No articles in this tier for the last 12 months.

Market Mentions 4 - appeared in market wrap coverage

These are market wrap articles where The Hydration Pharmaceuticals Company (ASX:HPC) was mentioned. They reflect broader market coverage, not company-specific announcements.

Market Wrap - Week 25 (15 June -> 19 June) 2026

Healthcare Wrap - Week 19 (4 May -> 8 May) 2026

Healthcare Wrap - Week 18 (27 Apr -> 1 May) 2026

Healthcare Wrap - Week 8 (16 Feb -> 20 Feb) 2026